NCT01380522View on ClinicalTrials.gov

Bioavailability Study of Metronidazole Capsules Under Fed Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

August 31, 2002

Primary Completion Date

September 30, 2002

Study Completion Date

September 30, 2002

Conditions
To Determine the Bioequivalence Study Under Fed
Interventions
DRUG

Metronidazole

Capsules, single-dose, fed

DRUG

Flagyl

Capsules, single-dose, fed

Trial Locations (1)

H4N 2Y8

Algorithme Pharma Inc, Montreal

Sponsors

Collaborators (1)

Algorithme Pharma Inc
All Listed Sponsors
collaborator

Algorithme Pharma Inc

INDUSTRY

lead

Par Pharmaceutical, Inc.

INDUSTRY

NCT01380522 - Bioavailability Study of Metronidazole Capsules Under Fed Conditions | Biotech Hunter | Biotech Hunter